World’s biggest insulin producer’s drug approved in Japan

World’s biggest insulin producer’s drug approved in Japan

PanARMENIAN.Net - Denmark's Novo Nordisk A/S, the world's biggest insulin producer, said on Friday its diabetes treatment Tresiba had been approved in Japan. Novo Nordisk said in a statement it expected to launch Tresiba in the country as soon as price negotiations have been completed, Reuters reported.

 Top stories
Authorities said a total of 192 Azerbaijani troops were killed and 511 were wounded during Azerbaijan’s offensive.
In 2023, the Azerbaijani government will increase the country’s defense budget by more than 1.1 billion manats ($650 million).
The bill, published on Monday, is designed to "eliminate the shortcomings of an unreasonably broad interpretation of the key concept of "compatriot".
The earthquake caused a temporary blackout, damaged many buildings and closed a number of rural roads.
Partner news
---